Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05826561 · ClinicalTrials.gov registry record · NA

Developing a Childhood Asthma Risk Passive Digital Marker

A NA study, sponsored by Indiana University.

Terminated
Registry status
NA
Development phase
34
Enrollment target

NCT05826561 is a NA study that was terminated before completion, run by Indiana University. The registered enrollment target is 34 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05826561, a NA study, was terminated before completion, sponsored by Indiana University.

TERMINATED
Registry status
NA
Development phase
34 participants
Enrollment target

Study Summary

Underdiagnosis and undertreatment is a major problem in childhood asthma management, especially in preschool-aged children. Current prognostic approaches using risk-score based tools have poor-to-modest accuracy, are impractical, and have limited evidence of efficacy in clinical settings and hence are not widely used in practice. The objective of the study is to determine the usability, acceptability, feasibility, and preliminary efficacy of the childhood asthma passive digital marker (PDM) among pediatricians. The study will include practicing pediatricians within the IU Health Network.

Interventions

  • OTHER Childhood Asthma Passive Digital Marker

Trial Details

FieldValue
Enrollment Target 34 participants
Start Date 2024-06-01
Est. Completion 2025-06-16
Phase NA

Sponsor

Indiana University

890 total trials

What the Registry Record Tells You About NCT05826561

The ClinicalTrials.gov registry entry for NCT05826561 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Childhood Asthma Passive Digital Marker is the first listed.

NCT05826561 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05826561 about?

NCT05826561 is a clinical study titled "Developing a Childhood Asthma Risk Passive Digital Marker". Underdiagnosis and undertreatment is a major problem in childhood asthma management, especially in preschool-aged children. Current prognostic approaches using risk-score based tools have poor-to-modest accuracy, are impractical, and have limited evidence of efficacy in clinical settings and hence a...

What is the current status of trial NCT05826561?

This trial is currently terminated. It is a NA study. The enrollment target is 34 participants. The study started on 2024-06-01. Estimated completion is 2025-06-16.

What interventions are being tested in trial NCT05826561?

The interventions under investigation include: Childhood Asthma Passive Digital Marker (OTHER).

Who is sponsoring clinical trial NCT05826561?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.